PolyMed Biopharmaceuticals Co., Ltd., a Chinese‑based, internationally‑oriented biopharma innovator, announced the successful closure of its...
The National Medical Products Administration (NMPA) today issued the “Measures for the Administration of Drug...
The Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) announced today...
WuXi AppTec (Shanghai) Co., Ltd., a wholly‑owned subsidiary of Wuxi AppTec Co., Ltd. (SHA: 603259,...
Wuxi Apptec Co., Ltd. (SHA: 603259, HKG: 2359) today announced third‑quarter 2025 financial results, delivering...
Grand Pharmaceutical Group Limited (HKG: 0512), a China-based company, announced on October 26, 2025, that...
Novartis (NYSE: NVS) announced an agreement to acquire San Diego-based biotech Avidity Biosciences for USD...
Eli Lilly (NYSE: LLY) announced on October 24, 2025, that it will acquire gene therapy...
Alphamab Oncology (HKG: 9966), a China-based biotechnology company, announced on October 27, 2025, that its...
AstraZeneca (AZ, NASDAQ: AZN) announced on October 25, 2025, the launch of its sixth Global...
The Italian Chiesi Group announced on October 25, 2025, the successful launch of its innovative...
Chugai Pharmaceutical, a member of the Roche Group, announced on October 24, 2025, that it...
Innovent Biologics (HKG: 1801) announced on October 27, 2025, that its fourth Phase III clinical...
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (SHA: 688336), a China-based company, released its 2025 third-quarter...
Astellas Pharma (TYO: 4503) announced on October 27, 2025, the establishment of its first China...
Novartis (NYSE: NVS) announced on October 27, 2025, the signing of a strategic cooperation agreement...
British pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) and Syndivia announced on October 27, 2025, that...
Chongqing Zhifei Biological Co., Ltd’s (SHE: 300122) subsidiary, Chongqing Chenan Biopharmaceutical Co., Ltd., has received...
LEO Pharma announced on October 17, 2025, that it has submitted a New Drug Application...
Eli Lilly and Company (India) Pvt. Ltd. (Lilly) and Cipla Limited (BOM: 500087, NSE: CIPLA) today announced a...